Johnson Matthey Completes Acquisition of UK Manufacturing Facility

Johnson Matthey, a provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, completed its acquisition of pharmaceutical manufacturing capacity in Scotland, UK. The 109,000-square meter site was acquired to meet increasing demand for custom pharmaceutical services and active ingredients.

Located in Annan, Dumfries and Galloway, the site was originally commissioned and constructed by Glaxo in 1980 and was most recently owned by Bakhu Pharma. An immediate multimillion-pound refurbishment will soon be underway to update and enhance the operational and quality standards of the facility. Refurbishment at the Annan facility is set to start in early 2015, and the site is expected to be fully operational by early 2016.

Source: Johnson Matthey

Leave a Reply

Your email address will not be published. Required fields are marked *